TABLE 2.

Current Treatments Used to Treat EoE in Adolescents (Caregiver-Reported) and Adults (Self-Reported)

Survey question	Adolescents* (n=98)	Adults (n=103)
Which of the following medications are you (is your child) currently taking to treat EoE?†
n	98	103
Budesonide slurry	43 (43.9)	33 (32.0)
Fluticasone oral inhaler	39 (39.8)	41 (39.8)
Budesonide liquid (compounded)	5 (5.1)	6 (5.8)
Prednisone	4 (4.1)	11 (10.7)
Budesonide oral inhaler	4 (4.1)	7 (6.8)
Other‡	3 (3.1)	5 (4.9)

Data are presented as n (%) unless otherwise specified.

^*Minor changes to the wording were made for the adolescent survey to apply to a caregiver’s perspective; all differences in wording are shown in square brackets.

^†Participants could select responses from a prespecified list of orally administered corticosteroid medications. Categories were not mutually exclusive.

^‡Other corticosteroid medications included beclomethasone nasal or oral inhaler (adolescents, n=2; adults, n=0), flunisolide nasal or oral inhaler (adolescents, n=1; adults, n=1), mometasone oral inhaler (adolescents, n=0; adults, n=2), and triamcinolone acetonide (adolescents, n=0; adults, n=2).

EoE indicates eosinophilic esophagitis.